Ramalho F, Costa A, Pires A, Cabrita P, Serejo F, Correia A P, Fatela N, Clória H, Lopes J, Pinto H C, Marinho R, Raimundo M, Velosa J, Batista A, de Moura M C
Pathology Department, Hospital de Santa Maria, Lisbon, Portugal.
Dig Dis Sci. 2000 Jan;45(1):182-7. doi: 10.1023/a:1005442317680.
Our objective was to evaluate the histopathological features of chronic hepatitis C of 64 liver biopsies and to correlate this with the route of transmission of hepatitis C virus, the genotype of HCV, and the patient's age. Moderate chronic hepatitis was the most frequently observed (62.5%). Cirrhosis was observed in 14 patients (21.9%) and was more frequently found among patients over 40 years of age (34.3% vs. 6.9%, P = 0.025). The mean histopathological activity index (HAI) was significantly higher in the sporadic (10+/-3.1) than the posttransfusional (7.5+/-3.7) and the intravenous drug use (IVDU) groups (6.3+/-2.8) (P<0.02). Moreover the sporadic group showed more fibrosis (P<0.04) than the posttransfusional group. No liver cirrhosis was found in the IVDU group. The overall prevalence of HCV variants was: 54.7% type 1b, 4.6% type 1a, 37.5% type 2c, 1.6% type 2b, 1.6% type 2. The genotype distribution showed no relation to the HAI, hepatitis activity (grade), and fibrosis (stage) of the liver disease. In conclusion, the sporadic route of transmission of HCV was related to a more severe chronic hepatic disease, a finding that could influence future antiviral therapies. The predominance of HCV type 1b in this study reflects the higher frequency of this variant in our area. Our data suggests that the ultimate consequence of HCV chronic infection depends on patient age rather than on HCV genotype.
我们的目的是评估64例肝活检慢性丙型肝炎的组织病理学特征,并将其与丙型肝炎病毒传播途径、HCV基因型及患者年龄相关联。中度慢性肝炎最为常见(62.5%)。14例患者(21.9%)出现肝硬化,且在40岁以上患者中更常见(34.3%对6.9%,P = 0.025)。散发性(10±3.1)组的平均组织病理学活动指数(HAI)显著高于输血后组(7.5±3.7)和静脉吸毒(IVDU)组(6.3±2.8)(P<0.02)。此外,散发性组比输血后组显示出更多纤维化(P<0.04)。IVDU组未发现肝硬化。HCV变异体的总体流行率为:1b型54.7%,1a型4.6%,2c型37.5%,2b型1.6%,2型1.6%。基因型分布与肝病的HAI(组织病理学活动指数)、肝炎活动度(分级)及纤维化(分期)无关。总之,HCV的散发性传播途径与更严重的慢性肝病相关,这一发现可能会影响未来的抗病毒治疗。本研究中1b型HCV的优势反映了该变异体在我们地区的较高频率。我们的数据表明,HCV慢性感染的最终后果取决于患者年龄而非HCV基因型。